Evidence map›Paper›PMID 26301969›Full record

ArticleBone marrow transplantation2015

Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience.

R Nelson, J F Shapiro, J B Perkins, J Kim, T Nishihori, J Pidala, E Ayala, F L Locke, T Field, A Mishra and 9 more

Abstract readLetter
In one paragraph

Article in Bone marrow transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

R NelsonDepartment of Pharmacy, Moffitt Cancer Center, Tampa, FL, USA.
J F ShapiroDepartment of Pharmacy, Moffitt Cancer Center, Tampa, FL, USA.
J B PerkinsDepartment of Pharmacotherapy and Clinical Research, College of Pharmacy, University of South Florida, Tampa, FL, USA.
J KimDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
T NishihoriDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
J PidalaDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
E AyalaDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
F L LockeDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
T FieldDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
A MishraDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
M RichesDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
B BettsDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
L PerezDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
B YueDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
J L Ochoa-BayonaDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
M AlsinaDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
H FernandezDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
C AnasettiDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.
M A Kharfan-DabajaDepartment of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, FL, USA.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
NCI NIH HHS P30 CA076292
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationHistocompatibilityAdultAgedAntilymphocyte SerumFemaleGraft SurvivalGraft vs Host DiseaseHumansImmunosuppressive AgentsMaleMiddle AgedRetrospective StudiesSirolimusTacrolimusT-LymphocytesAntilymphocyte SerumImmunosuppressive AgentsSirolimusTacrolimus

Identifiers

PMID26301969
PMCPMC4863975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.